Transition Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 7

% Expired Patents = 100.0

CIPO Patents = 1

Forward Citations = 57

Loading Chart...

4 inventors (with patents filed for the assignee):

Tony Cruz (5 out of 5 patents)

Aleksandra Pastrak (5 out of 5 patents)

John J Nestor (2 out of 14 patents)

4. Eva Anne Turley (1 out of 11 patents)

5. David C Schriemer (0 patent)

6. Ole Hindsgaul (0 patent)

7 patents: Sort by Forward Citations

1. 7595294 - Vasoactive intestinal polypeptide pharmaceuticals (2009-09-29),

2. 7566691 - Vasoactive intestinal polypeptide pharmaceuticals (2009-07-28),

3. 7026355 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2006-04-11),

4. 6911429 - Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans (2005-06-28),

5. 6908611 - Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases (2005-06-21),

6. 6894033 - Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases (2005-05-17),

7. 6797727 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2004-09-28),

Company Overview

Transition Therapeutics is a biopharmaceutical company focused on the research and development of innovative therapies for the treatment of diseases with high unmet medical needs. Their approach centers on identifying promising compounds and advancing them through various stages of clinical development to bring important medications to market that can improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#212 in Toronto

#2,102 in Canada

Toronto, Canada

Transition Therapeutics, Inc.

Forward Citations = 57

4 inventors:

Tony Cruz (5 out of 5 patents)

Aleksandra Pastrak (5 out of 5 patents)

John J Nestor (2 out of 14 patents)

4. Eva Anne Turley (1 out of 11 patents)

5. David C Schriemer (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Transition Therapeutics, Inc.. Retrieved from https://idiyas.com/company/transition-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]